Ontology highlight
ABSTRACT: Background
Liver cancer is the fourth leading cause of cancer-related death globally which is estimated to reach more than 1 million deaths a year by 2030. Among liver cancer types, hepatocellular carcinoma (HCC) accounts for approximately 90% of the cases and is known to have a tumour promoting inflammation regardless of its underlying aetiology. However, current promising treatment approaches, such as immunotherapy, are partially effective for most of the patients due to the immunosuppressive nature of the tumour microenvironment (TME). Therefore, there is an urgent need to fully understand TME in HCC and discover new immune markers to eliminate resistance to immunotherapy.Methods
We analyse three microarray datasets, using unsupervised and supervised methods, in an effor
SUBMITTER: Bahcivanci B
PROVIDER: S-EPMC9844659 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature